What the Future of GLP-1 Receptor Agonist Work Looks like After Coronavirus
Diabetes
caused by GLP-1 agonists is the most common type of diabetes and is
characterized by high levels of glucose (sugar) in the blood. Although some
symptoms may be similar, it is not the same as type 1 diabetes. Diabetes drugs are GLP-1 agonists that not only improve blood sugar control but may also
lead to weight loss.
This class
of drugs is known as glucagon-like peptide 1 receptor agonists or GLP-1
receptor agonists. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors
are another class of medications linked to weight loss and better blood sugar
control. Canagliflozin, dapagliflozin, and empagliflozin are examples. If
you're actively trying to lose weight through lifestyle changes and adding one
of these medications to your regimen, lowering blood sugar levels is beneficial
for managing type 2 diabetes, but it's unclear how GLP-1 receptor agonist drugs
cause weight loss. GLP-1s appear to help suppress appetite, according to
doctors. These medications also slow the passage of food from the stomach to
the small intestine. As a result, you may feel full faster and for a longer
period of time, causing you to eat less.
The drugs
already mentioned are intended for people with type 2 diabetes. Saxenda, a drug
containing a higher dose of liraglutide, is also approved for the treatment of
obesity in people who do not have diabetes. GLP-1 and SGLT-2 inhibitors appear
to have additional significant benefits in addition to helping to control blood
sugar and boost weight loss. Some drugs in these classes of medications,
according to research, may reduce the risk of heart disease, including heart
failure, stroke, and kidney disease. People taking these medications have seen
improvements in their blood pressure and cholesterol levels, though it is
unclear whether these improvements are due to the medication.
If you have a personal or family history of
medullary thyroid cancer or multiple endocrine neoplasias, you should avoid the
GLP-1 class of drugs. Laboratory studies have linked these drugs to thyroid
tumors in rats, but the risk to humans is unknown until more long-term studies
are completed. They are also not advised if you have had pancreatitis.
Comments
Post a Comment